Drug Shortage Report for LAMICTAL
| Report ID | 12467 |
| Drug Identification Number | 02240115 |
| Brand name | LAMICTAL |
| Common or Proper name | Lamotrigine chewable/dispersible tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LAMOTRIGINE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28's |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2017-07-17 |
| Estimated end date | 2017-09-07 |
| Actual end date | 2017-09-08 |
| Shortage status | Resolved |
| Updated date | 2017-09-13 |
| Company comments | For emergency supply, contact GSK Customer Service 1-800-387-7374. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2017-09-13 | French | Compare |
| v7 | 2017-09-13 | English | Compare |
| v6 | 2017-07-19 | French | Compare |
| v5 | 2017-07-19 | English | Compare |
| v4 | 2017-06-21 | French | Compare |
| v3 | 2017-06-21 | English | Compare |
| v2 | 2017-06-09 | French | Compare |
| v1 | 2017-06-09 | English | Compare |
Showing 1 to 8 of 8